According to a new report Asia Pacific Urinary Incontinence Devices Market, published by KBV research, the Asia Pacific Urinary Incontinence Devices Market would witness market growth of 12.3% CAGR during the forecast period (2018 – 2024).
The Japan market would dominate the Asia Pacific Internal Urinary Incontinence Devices by 2024, growing at a CAGR of 10.4 % during the forecast period. The China market is expected to witness a CAGR of 10.5% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 12.6% during (2018 - 2024).
The Stress Incontinence market dominated the Asia Pacific Urinary Incontinence Devices Market by Incontinence Type in 2017, achieving a market value of $383.3 million by 2024. The Overflow Incontinence market is expected to witness a CAGR of 12.6% during (2018 - 2024). The Urge Incontinence market is expected to witness a CAGR of 13.1% during (2018 - 2024).
The China Urinary Incontinence Devices Market attained a market size of $111.3 million in 2017 and it is expected to reach $237 million by 2024, growing at a CAGR of 11.5% during 2018 -2024.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants
By Incontinence Type
Unique Offerings from KBV Research